COVRIXNAY Trademark

Trademark Overview


On Wednesday, March 16, 2022, a trademark application was filed for COVRIXNAY with the United States Patent and Trademark Office. The USPTO has given the COVRIXNAY trademark a serial number of 97315552. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Thursday, April 27, 2023. This trademark is owned by GlaxoSmithKline Biologicals SA. The COVRIXNAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
covrixnay

General Information


Serial Number97315552
Word MarkCOVRIXNAY
Filing DateWednesday, March 16, 2022
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateThursday, April 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording COVRIXNAY has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, April 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Thursday, April 27, 2023ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Thursday, April 27, 2023ABANDONMENT - AFTER INTER PARTES DECISION
Thursday, April 27, 2023OPPOSITION TERMINATED NO. 999999
Thursday, April 27, 2023OPPOSITION SUSTAINED NO. 999999
Thursday, January 26, 2023OPPOSITION INSTITUTED NO. 999999
Thursday, January 26, 2023OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, December 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 22, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, November 18, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, November 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 15, 2022ASSIGNED TO EXAMINER
Tuesday, August 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 2, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, August 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 19, 2022NEW APPLICATION ENTERED